Evidence map›Paper›PMID 16883063›Full record

ArticleMediators of inflammation2006

Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.

Wanda F Reynolds, Isabelle Sermet-Gaudelus, Valérie Gausson, Marie-Noëlle Feuillet, Jean-Paul Bonnefont, Gérard Lenoir, Béatrice Descamps-Latscha, Véronique Witko-Sarsat

Abstract read
In one paragraph

Article in Mediators of inflammation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Biosynthesis of human myeloperoxidase.Archives of biochemistry and biophysics · 2018
    Review
  4. Review
  5. Redox balance in cystic fibrosis.The international journal of biochemistry & cell biology · 2014
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Oxidants and the pathogenesis of lung diseases.The Journal of allergy and clinical immunology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wanda F ReynoldsSidney Kimmel Cancer Center, San Diego, CA 92121, USA.
Isabelle Sermet-Gaudelus
Valérie Gausson
Marie-Noëlle Feuillet
Jean-Paul Bonnefont
Gérard Lenoir
Béatrice Descamps-Latscha
Véronique Witko-Sarsat

Funding

MYELOPEROXIDASE INVOLVEMENT IN ALZHEIMER'S DISEASER01AG017879 · NIA · SIDNEY KIMMEL CANCER CENTER · PI REYNOLDS, WANDA F · 2001 to 2005
$1.9M
NIA NIH HHS R01 AG017879NIA NIH HHS R01 AG17879
6 · The paper itself

Abstract

The severity of cystic fibrosis (CF) pulmonary disease is not directly related to CFTR genotype but depends upon several parameters, including neutrophil-dominated inflammation. Identification of agents modulating inflammation constitutes a relevant goal. Myeloperoxidase (MPO) is involved in both microbicidal and proinflammatory neutrophil activities. The aim of this study was to evaluate whether the -463GA MPO promoter polymorphism is linked to clinical severity of CF-associated pulmonary inflammation. This polymorphism significantly affects the level of MPO gene expression in leukocytes and the G allele is more expressing than the A allele. We show that MPO genotype significantly influences the severity of pulmonary disease in early stages, prior to the development of chronic lung infections, with GG genotype being associated with more severe CF disease. Our findings indicate that the level of MPO gene expression influences the CF pathogenesis, presumably reflecting cellular damage by MPO-generated oxidants or other activity of MPO in airway inflammation.

Indexed as

Gene Expression Regulation, EnzymologicPolymorphism, GeneticPromoter Regions, GeneticAdolescentAdultAllelesCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorFemaleGenotypeHumansLungMalePeroxidaseSex FactorsCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorPeroxidase

Identifiers

PMID16883063
PMCPMC1592586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.